In the US alone, millions of people each year face avoidable illnesses or death caused by this problem. This situation is estimated to cost the US healthcare system alone as much as $528 billion per year in likely avoidable spending. Billions more in potential market investments are sitting on the sidelines because of sectoral fragmentation. The problem is much larger at global scale.

Baseline research for the RAPID Alliance was completed in 2021, and published in the Journal of the American Pharmacists Association. Based on the research, goals for the RAPID Alliance from 2022 - 2031 were established. These are to rapidly accelerate innovation in order to improve health and wellbeing for 200+ million people in the US and 400+ million internationally, and reduce likely avoidable health spending in the US by up to $200 billion annually, by reducing medication related adverse health events (AHEs).

LOUISVILLE, Kentucky. Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually.

The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector, including all key professions, to share, fund and implement transformational innovations with potential to solve this challenge.

Of the event, Intrinsica Co-Founder and Chief Science Officer, Dr. Judah Thornewill, said "we are excited to be taking this next step to address this difficult challenge. At the event, we are also pleased to be using the first version of Intrinsica Accelerate,™ our research-driven platform for accelerating innovation at ecosystem scales.

The agenda includes information about plans to raise up to $25M in 2022, and $5 billion or more (cumulative) over the next decade, to support hundreds of public and private sector innovations to help solve this problem.

To sign-up, please visit spring2022.intrinsica.org.

About Intrinsica and the RAPID Alliance. Intrinsica, Inc. is a non-profit organized to accelerate innovation to solve some of societies most difficult challenges. The RAPID Alliance is Intrinsica's first innovation network, organized to solve a $528 billion medication and vaccine use challenge in the US, expanding globally.

Thank you to our Practice Council members for their vision of co-creating a national research infrastructure designed to support strategic action with potential to make a transformational difference. Thank you to selected Research Council members for guidance to help strengthen the study design.